Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.
Oemrawsingh RM, Akkerhuis KM, Van Vark LC, Redekop WK, Rudez G, Remme WJ, Bertrand ME, Fox KM, Ferrari R, Danser AH, de Maat M, Simoons ML, Brugts JJ, Boersma E; PERGENE investigators. Oemrawsingh RM, et al. Among authors: de maat m. J Am Heart Assoc. 2016 Mar 28;5(3):e002688. doi: 10.1161/JAHA.115.002688. J Am Heart Assoc. 2016. PMID: 27021566 Free PMC article. Clinical Trial.
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
Brugts JJ, de Maat MP, Boersma E, Witteman JC, van Duijn C, Uitterlinden AG, Bertrand M, Remme W, Fox K, Ferrari R, Danser AH, Simoons ML; EUROPA-PERGENE investigators. Brugts JJ, et al. Among authors: de maat mp. Cardiovasc Drugs Ther. 2009 Apr;23(2):171-81. doi: 10.1007/s10557-008-6156-1. Epub 2008 Dec 10. Cardiovasc Drugs Ther. 2009. PMID: 19082699
Biological variation in inflammatory and hemostatic markers.
Rudez G, Meijer P, Spronk HM, Leebeek FW, ten Cate H, Kluft C, de Maat MP. Rudez G, et al. Among authors: de maat mp. J Thromb Haemost. 2009 Aug;7(8):1247-55. doi: 10.1111/j.1538-7836.2009.03488.x. Epub 2009 Jun 30. J Thromb Haemost. 2009. PMID: 19566543 Free article.
Logistics and quality control for DNA sampling in large multicenter studies.
Nederhand RJ, Droog S, Kluft C, Simoons ML, de Maat MP; Investigators of the EUROPA trial. Nederhand RJ, et al. Among authors: de maat mp. J Thromb Haemost. 2003 May;1(5):987-91. doi: 10.1046/j.1538-7836.2003.00216.x. J Thromb Haemost. 2003. PMID: 12871366 Free article.
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
Monraats PS, Kurreeman FA, Pons D, Sewgobind VD, de Vries FR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Huizinga TW, Eefting D, Quax PH, Frants RR, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: de maat mp, de vries fr, de winter rj. Genes Immun. 2007 Jan;8(1):44-50. doi: 10.1038/sj.gene.6364343. Epub 2006 Nov 23. Genes Immun. 2007. PMID: 17122782
410 results